China (Mainland)
Hot Sale High Quality Mirabegron Powder Mirabegron intermediates with Best Price CAS NO.223673-61-8
- FOB Price: USD: 1,530.00-1,530.00 /Metric Ton Get Latest Price
- Min.Order: 100 Gram
- Payment Terms: L/C,T/T,Other
- Available Specifications:
AAAAA(1-5)Metric Ton
- Product Details
Keywords
- Mirabegron
- 223673-61-8
- Mirabegron price
Quick Details
- ProName: Hot Sale High Quality Mirabegron Powde...
- CasNo: 223673-61-8
- Molecular Formula: C21H24N4O2S
- Appearance: powder
- Application: pharmacetuical,health supplement
- DeliveryTime: 1-3 days
- PackAge: 1kg/bag, 25kg/drum
- Port: shanghai,beijing,guangzhou, HK
- ProductionCapacity: 100 Kilogram/Week
- Purity: 99%
- Storage: Far from fire and heat, keep in cool p...
- Transportation: by express, dhl,tnt,ems by air, by sea
- LimitNum: 100 Gram
- Related Substances: Related shall be not more than 10% 0...
- Residue on Ignition: 0.08%
- Heavy Metal: <1ppm
- Valid Period: 24 months
Superiority
Free sample, low freight, fast delivery, payment assurance, 24 hours service,high purity, good effect,good feedback, lead time:1-3 days, payment terms: TT, alibaba, , factory supplier, recruit overseas agents, welcome inquiry.
Details
Hot Sale High Quality Mirabegron 223673-61-8 with Best Price
Product Name: Mirabegron
Appearance: White powder
Application : Pharmaceutical raw materials
Factory: Large Output
Purity: 99%
MOQ:1 kg
Shelf life : 2 Years
Brand:HNB
Mirabegron is a selective beta 3 - epinephrine stimulant for bladder hyperactivity disorder.
|
Name |
Mirabegron |
|
Synonyms |
2-Amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-4-thiazoleacetamide |
|
Brand |
Salus |
|
Molecular Formula |
C21H24N4O2S |
|
Molecular Weight |
396.51 |
|
CAS Registry Number |
223673-61-8 |
What is Mirabegron
Mirabegron is a selective beta 3 - epinephrine stimulant for bladder hyperactivity disorder.
Indications: Mirabegron is used to treat urinary bladder urgency, frequency of urination, and urinary incontinence.
There are two known crystalline types (alpha and beta).
Application:
For special people
(1) Pregnancy is only used if the benefit to the mother exceeds the potential risk to the fetus.
(2) Lactating mother: It is expected that Myrbetriq will be excreted in human milk, and breastfeeding mothers are not recommended.
(3) Children: Children with the safety and efficacy of Myrbetriq have not yet been established.
(4) Elderly: It is recommended that elderly patients do not adjust the dose.